Amneal Pharmaceuticals, Inc. AMRX Specialty — Employee compensation and benefits
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LaborAndRelatedExpense.
The official record: Amneal Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amneal Pharmaceuticals, Inc.'s specialty — employee compensation and benefits.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amneal Pharmaceuticals, Inc.'s specialty — employee compensation and benefits?
- Amneal Pharmaceuticals, Inc. (AMRX) reported specialty — employee compensation and benefits of $11.94M in Q1 2026.
- How has Amneal Pharmaceuticals, Inc.'s specialty — employee compensation and benefits changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s specialty — employee compensation and benefits increased by 9.8% year-over-year, from $10.87M to $11.94M.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s specialty — employee compensation and benefits?
- Over 3 years (2022 to 2025), Amneal Pharmaceuticals, Inc.'s specialty — employee compensation and benefits has grown at a 7.8% compound annual growth rate (CAGR), from $34.89M to $43.71M.
- What does specialty — employee compensation and benefits mean?
- Includes all salary, wages, and benefit-related costs for personnel dedicated to the specialty segment. This metric helps assess the human capital investment required to support the segment's commercial and operational activities.